Ruediger Weseloh

Ruediger Weseloh Ph.D

Non-Executive Director

Rudiger joined Merck KGaA, Darmstadt, Germany, as a Senior Licensing Manager in 2006. Since then he held various positions in BD now as a Senior Director. In almost 13 years of doing Business Development for Merck KGaA, Darmstadt, Germany, Rudiger has led more than 50 transactions for its pharmaceutical division, across the drug development value chain in the fields of Oncology, Rheumatology, Neurodegenerative diseases, and Fertility. Before Merck KGaA, Rudiger spent 5 years as a Biotech/Pharma Equity Analyst, at Gontard & Metallbank, Frankfurt, and Sal. Oppenheim, Cologne/Frankfurt, and 3 years at the Max-Planck-Institute for Experimental Medicine in Gottingen. Has a university diploma in Biochemistry from the University of Hannover and a PhD in Molecular Neurobiology, obtained at the Center for Molecular Neurobiology in Hamburg.

Photograph © Eva Speith, Darmstadt - www.lichtbildatelier.de